autologous crispr-cas9 engineered regnase-1/socs1 dual-edited tumor infiltrating lymphocytes ksq-004ex

Generic: Autologous CRISPR-Cas9 Engineered Regnase-1/SOCS1 Dual-edited Tumor Infiltrating Lymphocytes KSQ-004EX

Get deeper analysis on autologous crispr-cas9 engineered regnase-1/socs1 dual-edited tumor infiltrating lymphocytes ksq-004ex

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    autologous crispr-cas9 engineered regnase-1/socs1 dual-edited tumor infiltrating lymphocytes ksq-004ex — Drug Pipeline, Trials & FDA Status | BioSniper